ORBIMED ADVISORS LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$7.1B
Holdings
132
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (132 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | EPIEURESSA PHARMA INC | 1,471,853 | $9.1B | 128.47% | |
| 102 | PGNYPROGYNY INC | 341,004 | $8.8B | 123.91% | |
| 103 | IMVTIMMUNOVANT INC | 354,575 | $8.6B | 121.55% | |
| 104 | ANABANAPTYSBIO INC | 375,800 | $8.4B | 118.19% | |
| 105 | XTNTXTANT MED HLDGS INC | 9,248,678 | $8.3B | 117.19% | |
| 106 | TXG10X GENOMICS INC | 92,700 | $8.3B | 116.56% | |
| 107 | TCE2CELLDEX THERAPEUTICS INC NEW | 625,000 | $8.1B | 114.39% | |
| 108 | RCKTROCKET PHARMACEUTICALS INC | 382,400 | $8.0B | 112.68% | |
| 109 | —AKOUOS INC | 315,000 | $7.1B | 99.79% | |
| 110 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $6.5B | 91.40% | |
| 111 | —APTOSE BIOSCIENCES INC | 950,841 | $6.0B | 84.47% | |
| 112 | SELBUSDSELECTA BIOSCIENCES INC | 2,093,869 | $5.9B | 83.73% | |
| 113 | 1K0IGM BIOSCIENCES INC | 80,760 | $5.9B | 82.99% | |
| 114 | VRNAVERONA PHARMA PLC | 1,250,396 | $5.9B | 82.39% | |
| 115 | RNAAVIDITY BIOSCIENCES INC | 200,000 | $5.7B | 79.57% | |
| 116 | RCUSARCUS BIOSCIENCES INC | 220,350 | $5.5B | 76.74% | |
| 117 | HCATHEALTH CATALYST INC | 179,598 | $5.2B | 73.76% | |
| 118 | —CALLIDITAS THERAPEUTICS AB | 225,000 | $5.2B | 73.49% | |
| 119 | ARNAEURARENA PHARMACEUTICALS INC | 66,700 | $4.2B | 59.12% | |
| 120 | —SYNLOGIC INC | 2,029,996 | $4.1B | 58.02% | |
| 121 | —KITOV PHARMA LTD | 3,461,983 | $3.8B | 54.10% | |
| 122 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $3.1B | 44.11% | |
| 123 | IFRXINFLARX NV | 678,525 | $3.1B | 43.84% | |
| 124 | ARWRARROWHEAD PHARMACEUTICALS IN | 68,100 | $2.9B | 41.41% | |
| 125 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 350,000 | $2.9B | 41.35% | Put |
| 126 | NTLAINTELLIA THERAPEUTICS INC | 137,100 | $2.9B | 40.57% | |
| 127 | —CURIS INC | 1,241,494 | $1.5B | 21.15% | |
| 128 | —NOVUS THERAPEUTICS INC | 3,183,314 | $1.5B | 20.54% | |
| 129 | BMY-RBRISTOL-MYERS SQUIBB CO | 350,000 | $1.3B | 17.64% | |
| 130 | —MENLO THERAPEUTICS INC | 593,883 | $1.0B | 14.46% | |
| 131 | ARVNARVINAS INC | 29,400 | $986.0M | 13.88% | |
| 132 | —BIOLINERX LTD | 69,240 | $118.0M | 1.66% |
PreviousPage 2 of 2